MarketAxess SEF and Traiana Complete First Live Trade With

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MarketAxess SEF and Traiana Complete First Live Trade With Pre-Trade Credit Checks

NEW YORK, Sept. 26, 2013 (GLOBE NEWSWIRE) -- Traiana and MarketAxess SEF Corporation today announce the completion of the first live credit default swap (CDS) index trade using Traiana's CreditLink service as the credit hub to verify pre-trade credit limits. JP Morgan acted as the clearing member for the major buy-side participant on the trade.

Under the Commodity Futures Trading Commission (CFTC) Swap Execution Facility (SEF) rules a clearing member must carry out pre-trade credit checks on trades prior to execution. CreditLink acts as a centralized hub and provides trading platforms, clearers/prime brokers, executing banks and buy-side firms the ability to monitor and manage pre- and post-trade credit in real-time across multiple trading venues in a consolidated view.

MarketAxess (Nasdaq: MKTX ) is the first trading platform to have been granted temporary registration as a SEF to be fully integrated and live with CreditLink, and the first platform on which a live trade was conducted with pre-trade credit checking via a credit hub.

Kevin McPherson, Head of U.S. Sales at MarketAxess, said: "The completion of this trade with a major buy-side participant and JP Morgan, using Traiana as a credit hub, is an important milestone in the implementation of the new SEF rules. A seamless credit checking process is critical in helping participants maintain liquidity in the swap markets. We have been working hard with all of the participants on our platform and the industry as whole to ensure the necessary infrastructure is in place well ahead of the SEF trading mandate."

Nick Solinger, Head of Product Strategy and Chief Marketing Officer, Traiana added: "This trade represents the significant investment the entire industry has made into ensuring the transition to SEF trading is smooth for clients and we are delighted that the process has been so seamless with MarketAxess. JP Morgan and MarketAxess have been leaders in building the infrastructure for certainty of execution and we look forward to working with them across our mutual client bases."

"Our clients require efficient and effective pre-trade credit checking processes," said Andres Choussy, global co-head of OTC clearing for J.P. Morgan. "In volatile markets, you can't afford to have your trade cancelled post execution, which is why we will continue working with Traiana, MarketAxess and the broader industry to ensure that each party to an electronic transaction has clearing commitments from their FCMs and the clearinghouses before their trade is executed."

About CreditLink

CreditLink provides trading platforms, clearers/prime brokers, executing banks and buy-side firms the ability to monitor and manage pre- and post-trade credit in real-time across multiple trading venues in a consolidated view. CreditLink supports all trading models across FX, exchange traded derivatives, CDS and fixed income and serves hundreds of buyside, broker, prime-brokers and trading venues.

About Traiana

Traiana, Inc. ( www.traiana.com ) provides global banks, broker/dealers, buy-side firms and trading platforms with services to monitor pre- trade risk and automate post-trade processing of financial transactions in listed and over-the-counter trading markets. Traiana's solutions and the Harmony Network have become the market standard for post-trade processing of foreign exchange, exchange traded derivatives, fixed income, CDS and synthetic and cash equity transactions. Traiana, an ICAP company, is headquartered in New York City with offices in Chicago, Hong Kong, London, Tel Aviv and Tokyo.

About MarketAxess

MarketAxess operates a leading electronic trading platform that enables fixed-income market participants to efficiently trade corporate bonds and other types of fixed-income instruments using MarketAxess' patented trading technology. Over 1,000 institutional investor and broker-dealer firms are active users of the MarketAxess trading platform, accessing global liquidity in U.S. high-grade corporate bonds, European bonds, high-yield and emerging markets bonds, agency bonds, asset-backed and preferred securities and credit default swaps. MarketAxess SEF Corporation has received temporary approval from the U.S. Commodity Futures Trading Commission to operate a swap execution facility. MarketAxess also offers a number of trading-related products and services, including: market data to assist clients with trading decisions; connectivity solutions that facilitate straight-through processing; technology services to optimize trading environments; and execution services for exchange-traded fund managers and other clients. Through its Xtrakter subsidiary, MarketAxess also offers a range of pre- and post-trade services, including trade matching, regulatory transaction reporting and market and reference data, across a range of fixed-income products.

MarketAxess maintains its headquarters in New York and has offices in London, Chicago, Salt Lake City, Hong Kong, Singapore and São Paulo. For more information, please visit  www.marketaxess.com .

MEDIA CONTACTS: MarketAxess Florencia Panizza +1-212-813-6029 Kyle White +44 (0) 20 7709 3219 Judi Flynn William McBride & Associates +1-917-902-8726 Traiana Candice Adam Argentus PR +44 (0)20 7397 2915

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 7

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

ANI Pharmaceuticals Executive Stock Sale Sparks Investor Interest

Updated Category News Views 53

Stock Sale by ANI Pharmaceuticals Executive ANI Pharmaceuticals Inc. (NASDAQ: ANIP) has recently gained attention due to a notable stock transaction involving one of its high-ranking officials. Meredith Cook, who serves as the Senior Vice President, General Counsel, and Secretary at the company, sold 250 shares of common stock. This sale, which amounted to about $14,205,...

Continue Reading
Welcoming Dr. Morales: A New Era for NewHydrogen's Innovation

Updated Category News Views 174

Welcoming Dr. Austin Morales to NewHydrogen Dr. Morales brings expertise in dynamic reactor operation and advanced catalytic processes. NewHydrogen, Inc. (OTCQB: NEWH), a pioneer in clean hydrogen technologies, is thrilled to announce Dr. Austin Morales’ addition to its talented UCSB Technology Team. With his extensive background in catalytic processes and reactor...

Continue Reading
42com Expands its Telecom Services in Italy with New Offerings

Updated Category News Views 111

42com Launches New ISP and Satellite Infrastructure Services 42com has dramatically expanded its service portfolio with the acquisition of assets from Milano Teleport Srl. This move has enabled the company to introduce valuable new services, including 24/7 Network Operations Center (NOC) support for LEO, VSAT, 5G, and IoT technologies. Establishing a Strong Presence in...

Continue Reading
AI Professionals Face Major Gaps in Tools and Confidence

Updated Category News Views 85

Understanding the Current Landscape of AI Professionals A recent survey unveiled concerning insights into the AI landscape, revealing that a mere 34% of AI professionals feel fully prepared to tackle the challenges associated with their organizations' AI objectives. This stark finding indicates a growing tension between AI investments and actual readiness within companies...

Continue Reading
Brazil's Meal Vouchers Market Poised for Growth with AI Insights

Updated Category News Views 513

Brazil's Meal Vouchers Market Poised for Growth The market for meal vouchers and employee benefit solutions in Brazil is projected to experience remarkable growth, with estimates indicating an increase of USD 9.96 billion from 2025 to 2029. This growth is largely fueled by the advantages offered by tax benefits and AI-driven innovations. As organizations search for ways...

Continue Reading